Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The United Laboratories International Holdings ( (HK:3933) ) has issued an update.
The United Laboratories International Holdings Limited has announced a placing of new shares under a general mandate, aiming to raise approximately HK$2,168.2 million in net proceeds. The funds will be allocated towards capital expenditure for expanding manufacturing facilities, enhancing external collaborations, and research and development, including clinical trials for innovative product candidates.
The most recent analyst rating on (HK:3933) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, primarily engaged in the pharmaceutical industry. It focuses on the manufacturing and development of pharmaceutical products, with a market focus on expanding its international business and strengthening external collaborations.
Average Trading Volume: 11,943,488
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.64B
See more data about 3933 stock on TipRanks’ Stock Analysis page.